QQ客服 官方微博 反馈留言

	Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model
	Chen, Kun; Wu, Zhiyuan; Zang, Mengya; Wang, Ce; Wang, Yanmei; Wang, Dongmei; Ma, Yifan; Qu, Chunfeng
	2018
卷号	10期号:6页码:1736-+
关键词	Cancer vaccine murine model T cells tumor-associated antigen hepatocellular carcinoma
ISSN号	1943-8141
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6356420
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Chen, Kun,Wu, Zhiyuan,Zang, Mengya,et al. Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model[J],2018,10(6):1736-+.
APA	Chen, Kun.,Wu, Zhiyuan.,Zang, Mengya.,Wang, Ce.,Wang, Yanmei.,...&Qu, Chunfeng.(2018).Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model.,10(6),1736-+.
MLA	Chen, Kun,et al."Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model".10.6(2018):1736-+.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。